GE Healthcare Life Sciences and SCIEX collaborate to expand multi-vendor service support in North America
Collaboration represents an extension to SCIEX Global Services’ strategy.
August 10, 2011
GE Healthcare, a unit of General Electric Company (NYSE: GE) and SCIEX today announced a collaboration agreement to provide GE Healthcare's Smart Asset Management Services (SAMS) customers throughout North America with the option for full on-site service and maintenance support of SCIEX mass spectrometry systems. This will enable customers to realize the convenience and productivity gains associated with SAMS, while maintaining access to the service and applications expertise of the original equipment manufacturer.
As a world-class provider of advanced technologies for life science research and biopharmaceutical manufacturing, GE Healthcare Life Sciences has developed SAMS, a portfolio of services for scientific asset management that enables consolidation of multi-vendor service support and provides insights into asset utilization. SAMS helps to simplify service operating models, reduce operating costs and improve overall productivity.
SCIEX is a global leader in mass spectrometry and a trusted partner to thousands of scientists and lab analysts worldwide. The company's Global Services organization provides a complete portfolio of best-in-class service and support for its mass spectrometry systems and software to protect customers' investments by minimizing costs and maximizing uptime of their systems.
To further strengthen the SAMS offering, GE Healthcare Life Sciences is actively building partnerships with leading original equipment manufacturers. Under the agreement announced today, SCIEX is able to supplement the on-site work of GE Healthcare service engineers with SCIEX service and support when needed. This partnering arrangement with an asset management service provider brings a variety of benefits to enhance efficiency, including a single point of contact for service support, and represents an extension to SCIEX Global Services' strategy.
"Laboratory managers are increasingly looking to have one point of contact for service and repair in order to reduce costs, reduce instrument down-time and increase productivity," said Eric Roman, President, Global Commercial Operations, GE Healthcare Life Sciences. "This agreement with SCIEX in North America is an illustration of our strategy to provide the highest quality service support for our customers."
"Partnering with asset management service providers, such as GE Healthcare Life Sciences, gives our customers more flexible options to obtain the level of support they need,"said Doug Onesko, vice president of SCIEX Global Services. "Working with GE Healthcare Life Sciences will help ensure delivery of exceptional quality service that our customers expect in the life science research and pharmaceutical fields."
About GE Healthcare:
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. Latest news of GE Healthcare.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company's global leadership and world-class service & support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery & development, food & environmental testing, forensics and clinical research. With over 20 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. Follow SCIEX on Twitter @ABSCIEX and on Facebook and LinkedIn
AB Sciex Instruments Are For Research Use Only. Not for use in diagnostic procedures. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEX™ is being used under license.